Arkolith/Insider Trading/IGMS/Form 4

Hambleton Julie

DirectorIGM Biosciences, Inc. (IGMS) · full profile →Form 4 · filed Jul 29, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$212K
Net Open-Market Flow
-$212K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 25, 2024Sell(S)15K$14.00$212K2K
Jul 25, 2024Option exercise(M)15K$1.39$21K17K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 25, 2024Option exercise(M)15K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-020266) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML